Nexora Pharma Retatrutide 30mg + Free BW
Nexora Pharma Retatrutide 30mg is a triple agonist peptide that activates GLP-1, GIP, and glucagon receptors. It enhances insulin secretion, increases energy expenditure, and reduces appetite, resulting in significant improvements in weight loss and metabolic regulation.
20 units available · For Research Use Only
Scientific Overview
Retatrutide is a triple agonist peptide that targets GLP-1, GIP, and glucagon receptors. Preclinical studies have explored its role in enhancing insulin secretion, increasing energy expenditure, and reducing appetite. While research indicates potential in weight management and metabolic regulation, further studies are needed to understand its full profile. Laboratory application only, not for human use.
Research Applications
- Significant weight loss
- Metabolic improvements
- Triple mechanism
Dosage Information
Reconstitute with appropriate solvent for laboratory use. Store at -20°C for optimal stability. Strictly for research use only, not for human consumption.